Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stephen John Lewis is active.

Publication


Featured researches published by Stephen John Lewis.


Bioorganic & Medicinal Chemistry Letters | 2000

2-Aryl tryptamines: selective high-affinity antagonists for the h5-HT2A receptor

Graeme Irvine Stevenson; Adrian Leonard Smith; Stephen John Lewis; Stephen G Michie; Joseph George Neduvelil; Smita Patel; Rosemarie Marwood; Shil Patel; José L. Castro

A series of 2-aryl tryptamines have been identified as high-affinity h5-HT2A antagonists. Structure-activity relationship studies have shown that h5-HT2A affinity can be attained via modifications to the tryptamine side chain and that selectivity over h5-HT2C and hD2 receptors can be controlled by suitable C-2 aryl groups.


Bioorganic & Medicinal Chemistry Letters | 2000

Solid-phase synthesis of 2,3-disubstituted indoles: discovery of a novel, high-affinity, selective h5-HT2A antagonist.

Adrian Leonard Smith; Graeme Irvine Stevenson; Stephen John Lewis; Smita Patel; Jose L. Castro

The application of a novel solid-phase synthesis of 2,3-disubstituted indoles utilizing a carbamate indole linker is described resulting in the identification of the novel, high-affinity, selective h5-HT2A antagonist 19.


Archive | 2001

Sulfamides as gamma-secretase inhibitors

Ian Collins; Joanne Claire Hannam; Timothy Harrison; Stephen John Lewis; Andrew Madin; Timothy Jason Sparey; Brian John Williams


Bioorganic & Medicinal Chemistry Letters | 2005

A novel series of potent γ-secretase inhibitors based on a benzobicyclo[4.2.1]nonane core

Stephen John Lewis; Adrian Leonard Smith; Joseph George Neduvelil; Graeme Irvine Stevenson; Matthew John Lindon; A. Brian Jones; Mark S. Shearman; Dirk Beher; Earl E. Clarke; Jonathan D. Best; James Peachey; Timothy Harrison; J. Luis Castro


Archive | 2001

Sulphonamido-substituted bridged bicycloalkyl derivatives

Patrice Charles Belanger; Ian Collins; Joanne Claire Hannam; Stephen John Lewis; Andrew Madin; Iver Edward Giles Mc; Alan Nadin; Joseph George Neduvelil; Mark S. Shearman; Adrian Leonard Smith; Timothy Jason Sparey; Graeme Irvine Stevenson; Martin Richard Teall


Bioorganic & Medicinal Chemistry Letters | 2006

The search for novel TRPV1-antagonists: From carboxamides to benzimidazoles and indazolones

Stephen Robert Fletcher; Edward Giles Mciver; Stephen John Lewis; Frank Burkamp; Clare Leech; Glenn Mason; Susan Boyce; Denise Morrison; Gillian Richards; Kathy Sutton; Anthony B. Jones


Archive | 1988

LIQUID CRYSTALLINE MIXTURE

Ian Charles Sage; Stephen John Lewis; Dominic Chaplin


Archive | 1987

Optically active naphthalene compounds and liquid crystal compositions containing them

John Anthony Jenner; Ian Charles Sage; Stephen John Lewis


Archive | 1987

OPTICALLY ACTIVE NAPHTHALENE COMPOUNDS AND LIQUID CRYSTAL MATERIALS AND DEVICES INCORPORATING THEM

John Anthony Jenner; Ian Charles Sage; Stephen John Lewis


Archive | 2006

Tetrahydroindole Derivatives for Treatment of Alzheimer's Disease

Frank Burkamp; Graham David Checksfield; Stephen Robert Fletcher; Stephen John Lewis; Edward Giles Mciver; Paul Joseph Oakley; Martin Richard Teall

Collaboration


Dive into the Stephen John Lewis's collaboration.

Researchain Logo
Decentralizing Knowledge